| 000 | 00617nam a2200205Ia 4500 | ||
|---|---|---|---|
| 005 | 20260808125346.0 | ||
| 008 | 260808s9999||||xx |||||||||||||| ||und|| | ||
| 035 | _a2778 | ||
| 041 | _aENG | ||
| 082 | _a615.11 | ||
| 100 | _aFeldmann, Edward G. | ||
| 245 | 0 |
_aNational formulary Board (1965-1969) _bNF+ supplement1,3,4,5 |
|
| 260 |
_aWashington _bAmerican Pharmaceutical Association _c1969 |
||
| 300 | _alxxiv + 1012 + 1193 | ||
| 500 | _a046A / 27.03.1970 | ||
| 505 | _aPharmacology; Drug Standards; Reference | ||
| 650 |
_aPharmacology _bPharmacology -- Therapeutics |
||
| 700 | _aBergen, John V. | ||
| 942 | _cBK | ||
| 999 |
_c2777 _d2777 |
||